Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study

William S Kerwin1, Kevin D O'Brien, Marina S Ferguson

  • 1Department of Radiology, Division of Cardiology, and Department of Surgery, University of Washington, 815 Mercer St, Seattle, WA 98109, USA. bkerwin@u.washington.edu

Radiology
|September 13, 2006
PubMed
Abstract

Insights

Magnetic resonance imaging (MRI) can noninvasively assess carotid plaque inflammation. The transfer constant (Ktrans) measured by MRI correlates with histologic markers of inflammation and cardiovascular risk factors like smoking and low HDL levels.

Area of Science:

  • Cardiovascular Imaging
  • Medical Physics
  • Biomedical Engineering

Background:

  • Atherosclerotic plaques pose a significant risk for cardiovascular events.
  • Identifying vulnerable plaques noninvasively is crucial for risk stratification.
  • Inflammation is a key driver of plaque instability.

Purpose of the Study:

  • To investigate the association between plaque enhancement on MRI and proinflammatory cardiovascular risk factors.
  • To evaluate the correlation between MRI-derived plaque content and histologic markers of inflammation.

Main Methods:

  • Contrast-enhanced MRI was used to measure contrast agent dynamics in carotid plaques of 30 patients.
  • Kinetic modeling estimated fractional plasma volume (vp) and transfer constant (Ktrans).
  • MR measurements were correlated with histologic plaque composition and clinical cardiovascular risk factors.

Main Results:

  • Ktrans measurements significantly correlated with macrophage content (r=0.75), neovasculature (r=0.71), and loose matrix (r=0.50).
  • Vp measurements also correlated with macrophage (r=0.54) and neovasculature (r=0.68) content.
  • Elevated Ktrans was associated with decreased high-density lipoprotein levels (r=-0.66) and smoking.

Conclusions:

  • Ktrans is a quantitative, noninvasive marker of plaque inflammation.
  • MRI-derived Ktrans reflects histologic markers of inflammation.
  • Ktrans correlates with key proinflammatory cardiovascular risk factors, including smoking and low HDL levels.